SI-BONE, Inc., a medical device company, develops implantable devices used in the surgical treatment of the sacropelvic anatomy in the United States and internationally. The company is headquartered in Santa Clara, California.
| Revenue (TTM) | $200.93M |
| Gross Profit (TTM) | $159.88M |
| EBITDA | $-16.56M |
| Operating Margin | -4.37% |
| Return on Equity | -11.00% |
| Return on Assets | -5.95% |
| Revenue/Share (TTM) | $4.68 |
| Book Value | $4.07 |
| Price-to-Book | 3.27 |
| Price-to-Sales (TTM) | 3.06 |
| EV/Revenue | 2.333 |
| EV/EBITDA | -14.15 |
| Quarterly Earnings Growth (YoY) | 0.00% |
| Quarterly Revenue Growth (YoY) | 15.00% |
| Shares Outstanding | $44.17M |
| Float | $42.72M |
| % Insiders | 3.62% |
| % Institutions | 97.89% |